Welcome to our dedicated page for Humana news (Ticker: HUM), a resource for investors and traders seeking the latest updates and insights on Humana stock.
Humana Inc. (HUM) is a leading health insurance provider specializing in government-sponsored healthcare programs and integrated wellness solutions. This dedicated news hub provides investors and industry professionals with timely updates on corporate developments, financial performance, and strategic initiatives shaping the healthcare sector.
Access authoritative information through verified press releases covering earnings announcements, Medicare Advantage plan expansions, Medicaid service updates, and partnerships in primary care innovation. Track regulatory filings related to prescription drug plans and pharmacy benefit management services critical to HUM's operations.
Key updates include insights into value-based care models, military health program (TRICARE) enhancements, and advancements in at-home healthcare services. All content is sourced directly from company communications to ensure accuracy for financial analysis and market trend evaluation.
Bookmark this page for streamlined access to HUM's latest operational milestones and healthcare industry leadership updates. Check regularly for objective reporting on developments impacting one of America's largest managed care organizations.
Humana Inc. (NYSE: HUM) has announced that Chief Financial Officer Susan M. Diamond will present at the Barclays Global Healthcare Conference on Tuesday, March 15, 2022, at 9:30 a.m. Eastern time. Investors can access a live audio webcast of the presentation on Humana's Investor Relations page. The company emphasizes its commitment to integrated care, aiming to improve the health and well-being of its members while lowering costs. Humana supports healthcare professionals through various clinical capabilities and resources.
Humana Inc. (NYSE: HUM) announced a plan to enhance its Board of Directors by appointing two new independent directors as part of a cooperation agreement with Starboard Value LP. This initiative aims to improve corporate governance and align with the company's growth strategies. Humana reiterated its long-term earnings growth target of 11-15% and a $1 billion value creation goal by 2023, while also focusing on expanding its Medicare Advantage market share and increasing pre-tax margins.
Humana Inc. (NYSE: HUM) has declared a cash dividend of $0.7875 per share, reflecting a 12.5% increase from the previous $0.70 dividend. This dividend is payable on April 29, 2022, to stockholders of record as of March 31, 2022. Humana aims to enhance health outcomes and manage costs through integrated care, benefiting millions of members, including Medicare recipients and military personnel. The company provides a range of resources, such as in-home care and behavioral health services, to simplify healthcare access and improve member well-being.
Humana Inc. (NYSE: HUM), in collaboration with The Humana Foundation and the University of Louisville, announced a $25 million investment in the Health Equity Innovation Hub. This initiative aims to enhance health equity for marginalized populations in Louisville and beyond. The funding includes $1.5 million from Humana and up to $13.5 million from The Humana Foundation, marking one of the largest donations in UofL’s history. The Hub will focus on research, talent development, and entrepreneurship, addressing social determinants of health to improve overall health outcomes.
Humana Inc. (NYSE: HUM) has received notification from the Louisiana Department of Health to award a contract for providing Medicaid coverage in Louisiana. The Medicaid division, Humana Healthy Horizons, plans to commence service later this year, contingent on completing the protest period. The initiative aims to enhance health outcomes for 1.6 million Medicaid beneficiaries in Louisiana through a holistic care approach. This selection underscores Humana's commitment to improving community health and supporting urgent needs through programs addressing social determinants of health.
Humana Inc. (NYSE: HUM) announced that CEO Bruce D. Broussard will present at the 11th Annual SVB Leerink Global Healthcare Conference on February 18, 2022, at 11:20 a.m. ET. Interested investors can access a live audio webcast on Humana’s Investor Relations page at humana.com. The company emphasizes its commitment to integrated healthcare, aiming to improve health and reduce costs for its members through various services, including in-home care and data analytics.
Humana Specialty Pharmacy announced the addition of two oncology therapies: TAGRISSO® (osimertinib) for EGFRm non-small cell lung cancer and LENVIMA® (lenvatinib) for various cancers. These drugs will be delivered directly to patients, supported by Humana's Oncology Center of Excellence, which offers expert guidance on treatment. Humana is dedicated to enhancing patient experiences and health outcomes while managing chronic and complex illnesses through personalized services.
Humana reported a 4Q21 loss per common share of $0.11 on a GAAP basis, while adjusted EPS stood at $1.24. For FY 2021, GAAP EPS was $22.67, down from $25.31 in FY 2020. The company anticipates FY 2022 GAAP EPS of at least $23.08 and adjusted EPS of at least $24.00, considering a $1.00 negative COVID-19 impact. Humana plans to create $1 billion in value through cost savings and productivity initiatives, focusing on its Medicare Advantage business and healthcare services expansion.
Humana Inc. (NYSE: HUM) has announced winners of its 2021 Go365 National Step Challenge, involving over 33,000 participants from various companies. Participants collectively logged 7.2 billion steps, leading to a donation of meals to local food banks, totaling an equivalent of one million meals. The challenge promotes health and community support, with winners from different divisions receiving donations in their names. The initiative has provided 4 million meals to Feeding America since its inception in 2018, addressing food insecurity while encouraging healthier lifestyles.